Skip to content

Grants to Waxman Consulting, Inc.

Amount Purpose Term Source
$532,311 To provide nonpartisan information and technical assistance to stakeholders to help lower prescription drug prices and commercial sector prices. 2021 - 2022 LJAF
$916,380 To provide information and technical support to help policymakers lower health care costs. 2019 - 2021 LJAF
$112,120 To develop a white paper outlining issues that are key for the succesful distribution of a COVID-19 vaccine. 2020 - 2022 LJAF
$74,497 To create an evidence-base to support the policy debate related to high prescription drug pricing. 2019 - 2020 LJAF
$207,774 To (i) research and analyze anticompetitive behaviors impacting prescription drug pricing, and (ii) provide nonpartisan information and technical support to key stakeholders and policymakers. 2019 - 2020 LJAF
$248,354 To inform ongoing investigations into pharmaceutical industry pricing practices. 2020 - 2021 LJAF
$503,352 To provide nonpartisan information and technical support to key stakeholders regarding prescription drug policy and publicly disseminate educational resources. 2018 - 2019 LJAF

Grants

Arnold Ventures funds projects to understand problems and identify policy solutions.

Map of the U.S. made of Arnold Ventures icons